Cytotoxic activity of biosynthesized nickel oxide nanoparticles against A549 lung cancer cell line
RSC Advances · 2026 · 16 (38) · 41612-41624
DOI: 10.1039/d5ra09967f ↗Kurz gefasst
Fachartikel in der Zeitschrift RSC Advances, 2026. Verfasst von Hendry Moses Panneerselvam und 1 weiteren Autor:innen. Beteiligte Einrichtung: PG & Research Department of Physics, Jamal Mohamed College (Autonomous), Affiliated with Bharathidasan University Tiruchirappalli-620020 Tamil Nadu I…. Die Arbeit nennt 82 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
The anticancer mechanism of PNNO NPs against A549 cancer cells involves ROS elevation, reduced membrane potential, and an increased BAX/BCL2 ratio via BCL2 downregulation, causing mitochondrial-mediated cell death.
Autor:innen und Institutionen
- PG & Research Department of Physics, Jamal Mohamed College (Autonomous), Affiliated with Bharathidasan University Tiruchirappalli-620020 Tamil Nadu India ebey_ebenezar@yahoo.com.
ORCID-Profile: Hendry Moses Panneerselvam, Ebenezar Jeyasingh
Zitieren
APA
Panneerselvam, H. M., & Jeyasingh, E. (2026). Cytotoxic activity of biosynthesized nickel oxide nanoparticles against A549 lung cancer cell line. RSC Advances, 16(38), 41612-41624. https://doi.org/10.1039/d5ra09967f
Vancouver
Panneerselvam HM, Jeyasingh E. Cytotoxic activity of biosynthesized nickel oxide nanoparticles against A549 lung cancer cell line. RSC Advances. 2026;16(38):41612-41624. doi:10.1039/d5ra09967f
BibTeX
@article{Panneerselvam2026,
author = {Panneerselvam, Hendry Moses and Jeyasingh, Ebenezar},
title = {Cytotoxic activity of biosynthesized nickel oxide nanoparticles against A549 lung cancer cell line},
journal = {RSC Advances},
year = {2026},
volume = {16},
number = {38},
pages = {41612--41624},
doi = {10.1039/d5ra09967f}
}
EUVIMED